THIAZOLO[5,4-B]PYRIDINE MALT-1 INHIBITORS
The present disclosure provides for compounds of the general Formula (I)wherein R1a, R1b, R2, R3, R4, R5, R6, R7, R8, and Ring A have any of the values defined in the specification, and pharmaceutically acceptable salts thereof..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Europäisches Patentamt - (2023) vom: 05. Okt. Zur Gesamtaufnahme - year:2023 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
COHEN DANIEL [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
Sonstige Themen: |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-10-05, Last update posted on www.tib.eu: 2023-11-09, Last updated: 2023-11-17 |
---|
Patentnummer: |
US2023312601 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA018398847 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA018398847 | ||
003 | DE-627 | ||
005 | 20231117101902.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231110s2023 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA018398847 | ||
035 | |a (EPA)US2023312601 | ||
035 | |a (EPA)86185307 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a COHEN DANIEL |e verfasserin |4 aut | |
245 | 1 | 0 | |a THIAZOLO[5,4-B]PYRIDINE MALT-1 INHIBITORS |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2023-10-05, Last update posted on www.tib.eu: 2023-11-09, Last updated: 2023-11-17 | ||
520 | |a The present disclosure provides for compounds of the general Formula (I)wherein R1a, R1b, R2, R3, R4, R5, R6, R7, R8, and Ring A have any of the values defined in the specification, and pharmaceutically acceptable salts thereof. | ||
650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
650 | 4 | |a che | |
650 | 4 | |a 615 | |
700 | 0 | |a GONG JANE |4 aut | |
700 | 0 | |a JAIN TARUN |4 aut | |
700 | 0 | |a KUMAR PUNEET |4 aut | |
700 | 0 | |a LIU DACHUN |4 aut | |
700 | 0 | |a MASTRACCHIO ANTHONY |4 aut | |
700 | 0 | |a MILLS MARK |4 aut | |
700 | 0 | |a PHILLIPS ANDREW WILLIAM |4 aut | |
700 | 0 | |a PRATT JOHN K |4 aut | |
700 | 0 | |a PUNNA SREENIVAS |4 aut | |
700 | 0 | |a STOCKWELL JENNIFER ANN |4 aut | |
700 | 0 | |a WANG LE |4 aut | |
700 | 0 | |a YU YIYUN |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 05. Okt. |
773 | 1 | 8 | |g year:2023 |g day:05 |g month:10 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/86185307/publication/US2023312601A1?q=US2023312601 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
936 | u | w | |j 2023 |b 05 |c 10 |
951 | |a AR | ||
952 | |j 2023 |b 05 |c 10 |